Ischemic Optic Neuropathy Clinical Trial
Official title:
Can Urgent Reduction of Intraocular Pressure With Ophthalmic Timolol Improve Recovery From Non-arteritic Anterior Ischemic Optic Neuropathy (NAION): a Randomized Study.
The purpose of this study is to evaluate the feasibility of rapid evaluation and administration of ophthalmic Timolol maleate in the treatment of non-arteritic anterior ischemic optic neuropathy. Secondary goals are to evaluate if such treatment reduces the progression or improves recovery of patients who are randomly assigned to treatment versus standard of care.
Non-arteritic anterior ischemic optic neuropathy (NAION) currently has no widely accepted acute treatment to improve recovery or prevent progression in the first month. It causes monocular vision loss with potential second eye involvement in 15% at 5 years. This leads to significant disability. It is the most common acute optic neuropathy in patients over 55 years of age. The final mechanism of injury is believed to be ischemic. Increasing perfusion of the optic nerve may reduce damage and prevent progression. Reduction in intraocular pressure has been shown to increase optic disc perfusion in animal models. Timolol maleate is a widely used medication for Glaucoma that reduces intraocular pressure. Treatment with Timolol maleate may improve optic disc perfusion in NAION and reduce ischemic damage from this condition. This study aims to enroll and treat patients with Timolol maleate 0.5% within 48 hours of symptom onset to assess feasibility of the study design and potential benefit of rapid intraocular pressure reduction. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02643615 -
Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery
|
N/A | |
| Active, not recruiting |
NCT00000126 -
Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)
|
N/A | |
| Completed |
NCT00000127 -
Ischemic Optic Neuropathy Decompression Trial (IONDT)
|
Phase 3 | |
| Recruiting |
NCT03475173 -
New Non-invasive Modalities for Assessing Retinal Structure and Function
|
N/A | |
| Completed |
NCT00450294 -
Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair
|
N/A | |
| Recruiting |
NCT03851562 -
Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
|
Phase 2 | |
| Recruiting |
NCT05353413 -
Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.
|
N/A | |
| Recruiting |
NCT02377271 -
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
|
Phase 3 | |
| Completed |
NCT01260324 -
Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
|